Manidipine Teva

Manidipine, the active ingredient in Manidipine Teva, is a calcium channel blocker presented as an oral tablet for systemic use. It selectively inhibits L‑type calcium channels in vascular smooth muscle, producing vasodilation that lowers elevated blood pressure in adults with hypertension, thereby contributing to the management of cardiovascular risk.

GNH USA supplies Manidipine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Manidipine is used to treat hypertension, a condition characterized by chronically elevated arterial pressure.

- Essential hypertension: reduces both systolic and diastolic blood pressure in patients with primary hypertension. - Secondary hypertension: may be added to other agents to achieve target blood pressure when an underlying cause is identified. - Isolated systolic hypertension: helps control elevated systolic pressure, particularly in older adults.

Manidipine may be associated with several adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often occurring shortly after initiation. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the lower limbs due to fluid accumulation. - Dizziness: sensation of light‑headedness, especially when standing quickly.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that can cause fainting. - Allergic reaction: rash, itching, swelling, or anaphylaxis in rare cases. - Liver injury: abnormal liver function tests or hepatitis.

When prescribing Manidipine, clinicians should consider several precautionary measures to ensure safe use.

- Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Hepatic impairment: use with caution and consider dose adjustment. - Concurrent antihypertensives: monitor for additive blood pressure lowering. - Elderly patients: start at a lower dose and titrate slowly. - Store at room temperature below 25°C: keep in the original container, protect from moisture.

Manidipine can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentrations. - Other antihypertensives: additive hypotensive effect can lead to severe blood pressure drop. - Grapefruit juice: can raise drug levels and risk of adverse events.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may reduce effectiveness. - Non‑dihydropyridine calcium channel blockers: may alter cardiac conduction. - NSAIDs: can blunt antihypertensive response and affect renal function.